2026-01-07 Steering Committee Meeting Notes
Date
Jan 7, 2026
Attendees
(bolded names indicate attendance)
Stakeholder group | SHIELD organization | Name of SHIELD member | organization designation |
Industry Entity | Labgnostic, Inc. | Steve Box | primary |
|
| alternate | |
Epic | Dan Rutz | primary | |
|
| alternate | |
Biomerieux | Xavier Gansel | primary | |
|
| alternate | |
Roche | Nick Decker | primary | |
Roche | Open | alternate | |
Healthcare Provider | Indiana University/Indiana University Health/Association for Molecular Pathology | Mehdi Nassiri, MD | primary |
University of Wisconsin-Madison | Andrea Pitkus, PhD, MLS(ASCP)CM, FAMIA | primary | |
UT Southwestern Medical Center | Hung Luu | primary | |
UNMC | Scott Campbell | primary | |
Longtime Lab Professional | Carmen Pugh | primary | |
Sonic Healthcare | Eric Crugnale | primary | |
Former Quest Diagnostics | Collom, Craig D | primary | |
Patient Advocate | OPEN | OPEN | individual |
Standards Organization | SNOMED International
| Jim Case | primary |
Monica Harry | alternate | ||
Regenstrief Institute
| Marjorie Rallins | primary | |
Eza Hafeza | alternate | ||
HL7
| Julia Skapik | primary | |
| alternate | ||
Professional Organization | Association of Public Health Laboratories
| Riki Merrick - regrets | primary |
Christina Gallegos - regrets | alternate | ||
Logica
| Stan Huff | primary | |
| alternate | ||
CAP
| Raj Dash - regrets | primary | |
| alternate | ||
AMP
| Robyn Temple | primary | |
| alternate | ||
Governmental - non Voting | CMS | Michael Smalara | primary |
Open | alternate | ||
ASTP/ONC | Sara Armson | primary | |
OPEN | alternate | ||
CDC | Hubert Vesper (/DDNID/NCEH/DLS) | primary | |
Jasmine Chaitram | alternate | ||
NLM | OPEN | primary | |
OPEN | alternate | ||
FDA | Keith Campbell? | primary | |
alternate |
Agenda and Notes
Item | Notes |
|---|---|
Quorum evaluation (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business) | Currently we have 17 named members (1 open slot, future 3 openings), so 2/3 = 11 is quorum (excluding chair and government members). # of voting member per charter: 13 - 21 # of non-voting members per charter: 7 Li Zha attended as guest. |
Open Meeting | 12:10 PM ET Adjourn 1:02 PM ET |
Steering Committee Membership | Vickie Derbyshire retired from FDA 12/19/2025 All of our terms expired Dec 20, 2025 eVote to extend the term of the current members to cover the missed 90 day announcement was sent on Dec 21, 2025 . As of 5Jan26, received 11 affirmative votes (100%) for the extension. 11 is quorum. Announcement for nomination requests was sent to the ALL SHIELD distribution list on 12/19/2025, nomination period ends Feb 20, 2026, then vote should be on first Steering Committee call in April = Apr 1, 2026 Started reviewing SHIELD Charter on terms expiring for organizations (currently 2 consecutive 3 terms - understand how that works for individual members vs organizations). Also participation, and number of Steering Committee members from each stakeholder group. Question arose on whether all Steering Committee members are elgible for re-election for another 3 year term. Answer is yes. However, at the end of 2028, re-elected members will be termed out and need to have a year hiatus before being eligible to return to Steering Committee. It is possible there could be turnover of majority of Steering Committee members at that time. It’ll also be dependent on how many new folks join Steering Committee this year. The participation Spreadsheet below indicates the term start and end dates in the far left columns for reference. Review participation for last 6 months: https://docs.google.com/spreadsheets/d/1QwCPA5haECNxPNAcJ8EeLzkxKcjxiktstlSJl3KpBOE/edit?gid=114687532#gid=114687532 Vacancies to be filled (as of 7Jan26)
Alignment of member terms with officer role terms. Federal partners participation? |
Conferences/Webinars/Annoucements of Interest | https://www.beckershospitalreview.com/healthcare-information-technology/ai/ai-begins-renewing-prescriptions-in-utah/ Stan mentioned Intermountain involved. Not enough physicians to take care of patients in Utah. Looking to reduce burden. Vendors tryign to automated straightforward renewals. See Communications and Branding WG updates below. No conferences currently. |
Next calls
| All SHIELD Calls
General Updates: 2024 - WG Chairs please make sure we have material for updates (at least notes we can link to) Special Topic: Jan 13, 2026 - Any Topic? No topics/speakers suggested today, so cancel. Steering Committee: Jan 21, 2026 CDC Forum Call in January 2026 would have been January 8th, so now looking for a date for Topic: UDI in HL7. Jasmine indicated that the next CDC Forum will likely be in March. |
Vision 2030 work | What the message to HHS Leadership should/could be - review the Lab Report and find those things where we can connect the dots to get traction on standards adoption Next steps:
|
THANK YOU to all the WG Chairs for their effort in moving SHIELD work forward!!! - will review again in January | |
Standards WG Vocab Follow up |
Discussion for today: How to distill this document and what to do with it
Communications and Branding WG Updates: Looking at presentations for 2026. Missed some windows. Did have good presentations in 2025. Will try to monitor better. IVD Data Hub WG Updates: Continued to be on pause. Looking at efforts, who’s driving, partnerships. LIDR WG Updates : White paper completed. Looking to draft journal article. HTI-5: HTI-5 Rulemaking from ONC emerged December 22, 2025. Public Comments due by Feb 27, 2026. If anything SHIELD should comment upon, please reach out ASAP. Otherwise, SHIELD may pass on commenting (since not much impacting laboratory data) on this rule. Folks are encouraged to review the video and other materials on the ONC website.
|
Placeholder to get back to later |
|
From Chat:
Integrated above, but includes AI prescribing in Utah, HTI-5 comment date, and CDC Forum informatoin.
Action items
Quick decisions not requiring context or tracking
For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.
- Add a decision…
Decisions requiring context or tracking
For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.